202610月
CVS Oct 2026 · Buy
CVS Health Corporation presents a compelling risk-adjusted Buy opportunity at $93.45, offering a 14.81% implied return to our synthesized intrinsic fair value of $107.29 as multi-year Medicare Advantage repricing and pharmacy services operating scale restore normalized enterprise earnings power.Latest published research · analyzed 2026-10-22 · current · sources aging